Applied DNA Closes the Loop on Traceability for Egyptian Pima with Genotyping Assays for Cotton Authentication
May 30 2019 - 8:00AM
Business Wire
Forensic Authentication of Cotton in Fiber,
Yarn, Fabric and Finished Goods
Applied DNA Sciences, Inc. (“Applied DNA,” “the Company,”
NASDAQ: APDN), today announced that it has closed the loop on
traceability for Egyptian Pima using DNA-based genotyping assays
for cotton authentication. These assays have been used to verify
fiber and will be extended to yarn, fabric and finished goods in an
ongoing validation program. The Egyptian Pima developments join and
expand a series of US Pima cotton assays performed within Applied
DNA testing services and are based on work conducted over the past
3 years related to the validation of a known library of cotton
cultivar standards.
“This solution closes the loop for the cotton industry that has
been under a cloud of controversy surrounding evidence of cotton
products labeled as Egyptian cotton versus those which are actually
grown in Egypt. There is no substitute for DNA analysis when it
comes to cotton traceability and transparency because of its
ability to do what other technologies cannot do, which is to
forensically authenticate the fiber through to yarn and finished
goods,” stated Dr. Michael Hogan, vice president, Life Sciences,
Applied DNA. When paired with SigNature® T DNA tagging, testing and
tracking of cotton at the gin, it is expected that these new cotton
assays, along with other methods of fiber quantitation in the
development pipeline at Applied DNA, can now broaden our
multiple-parameter analysis to verify the type of cotton, the
cotton’s origin, and the blending of the cotton fiber (both valid
and surreptitious) during the journey from the ginned fiber to a
finished textile product.
In August 2016, the controversy of home bedding and other
products labeled 100% Egyptian Cotton hit an all-time high when a
number of US retailers recalled many products from retail shelves
due to label claim violations, and consumers were informed that
products did not meet the standard or label requirement. Three
years later, Applied DNA will begin to validate and market test
products that are labeled to contain 100% Egyptian Pima in addition
to these services for US Pima. Recently, a federal judge ruled that
several “Big Box” stores must face lawsuits claiming they sold
linens falsely labeled “Egyptian Cotton.” Applied DNA believes its
new Egyptian genotyping assays could assist in protecting against
such an imbroglio if the retailers used this technology in their
supply chains to verify their goods.
“Our cotton authentication platform of SigNature T and
genotyping can provide a means for quality control and compliance
in supply chains. Many products use cotton grown in the US and
Egypt, and we believe that our system can provide a useful tool to
enable brands and manufacturers to verify their products at any
stage of the supply chain, that is more exact than other methods
claiming to do the same without the same degree of precision,”
stated Dr. James Hayward, president and CEO of Applied DNA.
“The Himatsingka Group remains committed to bringing cotton
traceability for all major varietals of cotton including Egyptian
cotton, while maintaining the highest standards of traceability
solutions and quality control mechanisms. We applaud Applied DNA
for advancing the solutions for the cotton industry as we believe
that DNA science is the new standard for purity and authenticity,”
stated Shrikant Himatsingka, CEO of The Himatsingka Group.
About Applied DNA Sciences
Applied DNA is a provider of molecular technologies that enable
supply chain security, anti-counterfeiting and anti-theft
technology, product genotyping and pre-clinical nucleic acid-based
therapeutic drug candidates.
Applied DNA makes life real and safe by providing innovative,
molecular-based technology solutions and services that can help
protect products, brands, entire supply chains, and intellectual
property of companies, governments and consumers from theft,
counterfeiting, fraud and diversion.
Visit adnas.com for more information. Follow us on Twitter and
LinkedIn. Join our mailing list.
Common stock listed on NASDAQ under the symbol APDN, and
warrants are listed under the symbol APDNW.
Forward-Looking Statements
The statements made by Applied DNA in this press release may be
“forward-looking” in nature within the meaning of the Private
Securities Litigation Act of 1995. Forward-looking statements
describe Applied DNA’s future plans, projections, strategies and
expectations, and are based on assumptions and involve a number of
risks and uncertainties, many of which are beyond the control of
Applied DNA. Actual results could differ materially from those
projected due to its history of net losses, limited financial
resources, limited market acceptance, ability to maintain its
NASDAQ listing and various other factors detailed from time to time
in Applied DNA’s SEC reports and filings, including our Annual
Report on Form 10-K filed on December 18, 2018 and our subsequent
quarterly reports on Form 10-Q filed on February 7, 2019 and May 9,
2019, and other reports we file with the SEC, which are available
at www.sec.gov. Applied DNA undertakes no obligation to update
publicly any forward-looking statements to reflect new information,
events or circumstances after the date hereof to reflect the
occurrence of unanticipated events, unless otherwise required by
law.
View source
version on businesswire.com: https://www.businesswire.com/news/home/20190530005208/en/
investor contact: Sanjay Hurry, LHA Investor Relations,
212-838-3777, shurry@lhai.commedia contact: Meryl Rader,
781-639-4924, meryl@cgprpublicrelations.comprogram contact: MeiLin
Wan, 631-240-8849, meilin.wan@adnas.comweb: adnas.comtwitter:
@APDN
Applied DNA Sciences (NASDAQ:APDN)
Historical Stock Chart
From Mar 2024 to Apr 2024
Applied DNA Sciences (NASDAQ:APDN)
Historical Stock Chart
From Apr 2023 to Apr 2024